Anteris Technologies Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
108
- Stock Symbol
-
AVR
- Investments
-
7
- Share Price
-
$6.84
- (As of Thursday Closing)
Anteris Technologies General Information
Description
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. It is also engaged in research and development of ComASUR, a delivery system that allows accurate valve placement, and the manufacturing and selling of proprietary ADAPT regenerative tissue products. The company generates a majority of its revenue from the United States and the rest from Switzerland and Australia.
Contact Information
Website
www.anteristech.comCorporate Office
- Toowong Tower, Level 3
- Suite 302, 9 Sherwood Road
- Toowong, Queensland 4066
- Australia
Corporate Office
- Toowong Tower, Level 3
- Suite 302, 9 Sherwood Road
- Toowong, Queensland 4066
- Australia
Anteris Technologies Timeline
Anteris Technologies Stock Performance
As of 05-Dec-2024, Anteris Technologies’s stock price is $6.84. Its current market cap is $144M with 21.1M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.84 | $6.48 | $5.61 - $15.86 | $144M | 21.1M | 28.6K |
Anteris Technologies Financials Summary
As of 30-Sep-2024, Anteris Technologies has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 172,374 | 221,824 | 188,827 | 92,938 |
| Revenue | 2,728 | 3,179 | 5,844 | |
| EBITDA | (44,109) | (28,971) | (15,100) | |
| Net Income | (44,689) | (30,710) | (17,184) | |
| Total Assets | 31,136 | 15,973 | 21,372 | |
| Total Debt | 1,708 | 957 | 4,153 |
Anteris Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Anteris Technologies Comparisons
Industry
Financing
Details
Anteris Technologies Competitors (7)
One of Anteris Technologies’s 7 competitors is Colibri Heart Valve, a Venture Capital-Backed company based in Louisville, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Colibri Heart Valve | Venture Capital-Backed | Louisville, CO | ||||
| NOVADIP | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | ||||
| Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
| Mimedx | Corporation | Marietta, GA | ||||
| JenaValve Technology | Pending Transaction (M&A) | Irvine, CA |
Anteris Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Anteris Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Anteris Technologies Investments & Acquisitions (7)
Anteris Technologies’s most recent deal was a Corporate with v2vmedtech. The deal was made on 19-Apr-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| v2vmedtech | 19-Apr-2023 | Corporate | Therapeutic Devices | ||
| Admedus Biomanufacturing | 31-Dec-2013 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Genzyme Australasia (Manufacturing site in Malaga) | 31-Dec-2013 | Corporate Asset Purchase | Buildings and Property | ||
| Coridon | 01-Jul-2013 | Secondary Transaction - Private | Biotechnology | ||
| Coridon | 27-Apr-2012 | Secondary Transaction - Private | Biotechnology |
Anteris Technologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Supplies
Subindustry
Rank
Percentile
Anteris Technologies FAQs
-
When was Anteris Technologies founded?
Anteris Technologies was founded in 1999.
-
Where is Anteris Technologies headquartered?
Anteris Technologies is headquartered in Toowong, Australia.
-
What is the size of Anteris Technologies?
Anteris Technologies has 108 total employees.
-
What industry is Anteris Technologies in?
Anteris Technologies’s primary industry is Therapeutic Devices.
-
Is Anteris Technologies a private or public company?
Anteris Technologies is a Public company.
-
What is Anteris Technologies’s stock symbol?
The ticker symbol for Anteris Technologies is AVR.
-
What is the current stock price of Anteris Technologies?
As of 05-Dec-2024 the stock price of Anteris Technologies is $6.84.
-
What is the current market cap of Anteris Technologies?
The current market capitalization of Anteris Technologies is $144M.
-
Who are Anteris Technologies’s competitors?
Colibri Heart Valve, NOVADIP, Orthofix International, Mimedx, and JenaValve Technology are some of the 7 competitors of Anteris Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
